GNTA · Genenta Science S.p.A. · Documents
Market Cap
$40.54M
Shares
48.22M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-11 | — | |
| 6-K | 2026-09-02 | 2026-09-01 | |
| 6-K | 2026-07-31 | — | |
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-17 | — | |
| 6-K | 2026-06-16 | — | |
| 6-K | 2026-05-29 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-04-28 | — | |
| 6-K | 2026-04-23 | — | |
| 6-K | 2026-04-14 | — | |
| 20-F | 2026-04-01 | 2025-12-31 | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-24 | 2026-03-23 | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2025-11-04 | 2025-10-31 | |
| 6-K | 2025-10-28 | — | |
| 6-K | 2025-10-27 | — | |
| 6-K | 2025-10-10 | 2025-06-30 | |
| 6-K | 2025-10-03 | — | |
| 6-K | 2025-09-10 | — | |
| 6-K | 2025-08-01 | — | |
| 20-F | 2025-03-28 | 2024-12-31 | |
| 6-K | 2025-03-19 | — | |
| 6-K | 2025-03-19 | — | |
| 6-K | 2024-12-30 | — | |
| 6-K | 2024-12-20 | — | |
| 6-K | 2024-12-13 | — | |
| 6-K | 2024-11-14 | — | |
| 6-K | 2024-10-29 | 2024-06-30 | |
| 6-K | 2024-05-03 | — | |
| 6-K | 2024-04-26 | — | |
| 6-K | 2024-04-08 | — | |
| 6-K | 2024-04-02 | — | |
| 20-F/A | 2024-04-01 | 2023-12-31 | |
| 20-F | 2024-03-29 | 2023-12-31 | |
| 6-K | 2023-10-20 | 2023-06-30 | |
| 6-K | 2023-06-14 | — | |
| 6-K | 2023-05-10 | — | |
| 6-K | 2023-05-01 | — | |
| 20-F | 2023-04-21 | 2022-12-31 | |
| 6-K | 2023-03-10 | — | |
| 6-K | 2023-02-01 | 2023-01-31 | |
| 6-K | 2022-12-22 | — | |
| 6-K | 2022-12-15 | — | |
| 6-K | 2022-10-25 | 2022-06-30 |
Showing 1–50 of 55 filings